VPC 14449

CAS No. 1621375-32-3

VPC 14449 ( VPC14449 )

Catalog No. M12386 CAS No. 1621375-32-3

VPC 14449 is a potent and selective androgen receptor DNA-binding domain (AR-DBD) inhibitor with IC50 of 0.34 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 224 Get Quote
50MG 897 Get Quote
100MG 1386 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    VPC 14449
  • Note
    Research use only, not for human use.
  • Brief Description
    VPC 14449 is a potent and selective androgen receptor DNA-binding domain (AR-DBD) inhibitor with IC50 of 0.34 uM.
  • Description
    VPC 14449 is a potent and selective androgen receptor DNA-binding domain (AR-DBD) inhibitor with IC50 of 0.34 uM, without affecting AR protein expression; effectively blocks transcriptional activity of full-length and splice variant AR forms at low to sub-micromolar concentrations; reduces tumor volume and abolishes PSA production in LNCaP xenograft model.
  • Synonyms
    VPC14449
  • Pathway
    Endocrinology/Hormones
  • Target
    Androgen Receptor (AR)
  • Recptor
    Androgen Receptor (AR)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1621375-32-3
  • Formula Weight
    394.09
  • Molecular Formula
    C10H10Br2N4OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    BrC1=C(Br)N=CN1C2=CSC(N3CCOCC3)=N2
  • Chemical Name
    4-(4-(4,5-dibromo-1H-imidazol-1-yl)thiazol-2-yl)morpholine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Dalal K, et al. Mol Cancer Ther. 2017 Aug 3. pii: molcanther.0259.2017.
2. Dalal K, et al. J Biol Chem. 2014 Sep 19;289(38):26417-29.
molnova catalog
related products
  • LGD-3303

    LGD-3303 is an orally available, brain-penetrant nonsteroidal selective androgen receptor modulator (SARM) that that shows little or no cross-reactivity with related nuclear receptors.

  • Flutamide

    Flutamide is an antiandrogen drug, with its active metablolite binding at androgen receptor.

  • Ailanthone

    Ailanthone is an effective inhibitor of both full-length androgen receptor (AR) (IC50: 69?nM) and constitutively active truncated AR splice variants (IC50: 309?nM).